Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Incyte
Company Monitoring Page for Incyte
job ratings for Incyte
10/25/17
industry:
Biotech
company:
Incyte
job rating:
1
Great product, incompetent impotent leadership. No one at the wheel.
09/11/17
industry:
Biotech/Pharmaceutical
job title:
Sales
company:
Incyte
job rating:
3
Over regulated,incompetent management,
latest headlines for company on cafepharma
Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial
Fierce Biotech
Mon, 03/11/24 - 11:52 am
Tags:
Incyte
,
clinical trials
,
prurigo nodularis
,
povorcitinib
,
Dupixent
,
Sanofi
,
Regeneron
Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs
Fierce Biotech
Wed, 01/24/24 - 10:35 am
Tags:
Synnovation Therapeutics
,
Incyte
,
AstraZeneca
,
GSK
,
Novartis
,
Pfizer
,
funding
,
cancer
,
PARP inhibitors
Incyte reports positive data from Phase III vitiligo trial
Clinical Trials Arena
Thu, 10/12/23 - 05:27 pm
Tags:
Incyte
,
Opzelura
,
vitiligo
,
clinical trials
Replimune and Incyte to study cancer combo therapy in CSCC patients
Clinical Trials Arena
Tue, 08/1/23 - 10:06 am
Tags:
Replimmune
,
Incyte
,
clinical trials
,
RP1
,
CSCC
,
cutaneous squamous cell carcinoma
Incyte’s trial of ruxolitinib cream meets primary endpoint
Clinical Trials Arena
Wed, 07/12/23 - 09:37 am
Tags:
Incyte
,
ruxolitinib
,
clinical trials
,
pediatric
,
atopic dermatitis
Blood cancer trial finds ruxolitinib better than current treatments
Clinical Trials Arena
Fri, 05/5/23 - 10:13 am
Tags:
clinical trials
,
polycythemia vera
,
Jakafi
,
Incyte
Incyte whittles down pipeline, scrapping 6 R&D programs
Fierce Biotech
Tue, 05/2/23 - 11:25 pm
Tags:
Incyte
,
R7D
,
anemia
,
cancer
Biotech heads towards big catalysts
EP Vantage
Tue, 03/28/23 - 10:24 am
Tags:
biotech
,
clinical trials
,
Alnylam Pharmaceuticals
,
Arcus Biosciences
,
Argenx
,
Arrowhead Pharmaceuticals
,
Axsome Therapeutics
,
Bavarian Nordic
,
FibroGen
,
Gilead Sciences
,
Incyte
,
Morphic Therapeutic
,
PTC Therapeutics
,
Syndax Pharmaceuticals
,
Travere Therapeutics
,
Vaxcyte
Incyte hit by CRL on extended-release JAK tablets, muddying plans for Jakafi franchise expansion
Endpoints
Fri, 03/24/23 - 10:05 am
Tags:
Incyte
,
FDA
,
ruxolitinib
,
CRL
In a surprise approval, FDA green-lights Incyte's PD-1 inhibitor to treat rare cancer type
Fierce Pharma
Wed, 03/22/23 - 09:27 pm
Tags:
Incyte
,
Zynyz
,
FDA
,
Merkel cell carcinoma
Incyte touts mid-stage data for new JAK inhibitor but stops short of selecting PhIII dose
Endpoints
Tue, 03/21/23 - 10:06 am
Tags:
AAD
,
Incyte
,
JAK inhibitors
,
povorcitinib
,
vitiligo
Incyte reports data from Phase IIb vitiligo therapy trial
Clinical Trials Arena
Mon, 03/20/23 - 11:27 am
Tags:
Incyte
,
povorcitinib
,
vitiligo
,
clinical trials
Incyte Abandons Phase III Trial for Myelofibrosis Treatment
BioSpace
Mon, 03/6/23 - 11:06 am
Tags:
Incyte
,
clinical trials
,
myelofibrosis
,
Jakafi
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
Tags:
FDA
,
Acadia Pharmaceuticals
,
Apellis Pharmaceuticals
,
AstraZeneca
,
Biogen
,
Biomarin
,
Cidara Therapeutics
,
Emergent BioSolutions
,
GSK
,
Incyte
,
Ionis Pharmaceuticals
,
Melinta Therapeutics
,
Mundipharma
,
Novartis
,
Pfizer
,
Pharming
,
Regeneron
,
Roche
,
vaccines
,
RSV
,
ALS
,
COVID-19
Incyte reports new data from hidradenitis suppurativa therapy trial
Clinical Trials Arena
Mon, 02/13/23 - 10:25 am
Tags:
Incyte
,
clinical trials
,
hidradenitis suppurativa
,
povorcitinib
Insmed, Alnylam and others make Science's list of top 20 biopharma employers
Endpoints
Sun, 11/6/22 - 01:32 pm
Tags:
employers
,
Inbsmed
,
Alnylam
,
Regeneron
,
Incyte
SITC 2022 preview – cytokines and oral checkpoints
EP Vantage
Thu, 10/6/22 - 10:39 am
Tags:
SITC
,
Incyte
,
ChemoCentryx
,
Amgen
,
cytokines
Incyte pays out $70M to get hands on Medicxi-backed vitiligo biotech
Endpoints
Mon, 10/3/22 - 10:21 am
Tags:
Incyte
,
M&A
,
Villaris Therapeutics
,
vitiligo
,
Medicxi
FDA Action Alert: Incyte, Arcutis Await Decisions in Vitiligo, Psoriasis
BioSpace
Mon, 07/18/22 - 10:22 am
Tags:
FDA
,
Incyte
,
Arcutis Biotherapeutics
,
Opzelura
,
vitiligo
,
roflumilast
,
psoriasis
MorphoSys Adds HIBio to Busy Collaboration Week
BioSpace
Wed, 06/15/22 - 11:03 am
Tags:
MorphoSys
,
HIBio
,
Pfizer
,
Incyte
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.